Company page

Prescient Therapeutics Limited

Prescient Therapeutics Limited (PTX) is a public company listed on the Australian market, with a market capitalization of approximately AUD 50.1 million. The company focuses on developing innovative therapies for cancer treatment. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.